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sequences) and associated with a type-1 IFN response. Induction of these genes by
autocrine type-I and type-III IFN signaling was ruled out using both neutralizing anti-
bodies to these IFNs in biological assays and qRT-PCR. Despite the absence of type-I or
type-III IFNs, IFN-c treatment induced ISGF3 formation and ISRE binding, as shown by
STAT2 co-immunoprecipitation and ChIP analysis of the PKR promoter. STAT2 and
IRF9 knockdown in A549 cells reversed IFN-c-mediated ISRE induction and antiviral
activity – implicating ISGF3 formation as a significant component of the cellular
response and biological activity of IFN-c.
doi:10.1016/j.cyto.2010.07.136
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Pellino 3 has been shown to be a negative regulator of TLR4 signalling. The pro-
cess by which the protein does this has yet to be elucidated. However, the phosphor-
ylation of Pellino 3 by IRAK-1 has been shown to initiate the E3 ligase activity of
Pellino 3. This E3 ligase activity in turn leads to the polyubiquitination and
subsequent degradation of IRAK-1. The Pellino Family also share a conserved fork-
headed associated (FHA) domain that binds to phosphorylated proteins. This FHA
region has already been shown to be crucial in Pellino 2, IRAK-1 binding and process-
ing. This study will examine other proteins within the TLR4 signalling cascade that
interact with Pellino 3 via the FHA region which then leads to their degradation. This
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Type I interferons (IFN-a and -b) are cytokines that activate primarily the JAK/
STAT pathway to induce an anti-proliferative, pro-apoptotic or antiviral response in
cells. We previously identified a motif in the SH2 domain of STAT2 that, when
mutated, prolonged nuclear retention of the STAT1/STAT2 heterocomplex during
IFN treatment and induced apoptosis in certain tumor cell lines. With the excep-
tion of STAT2, other members in the STAT family of transcription factors have been
shown to be phosphorylated on tyrosine and serine residues for biological activity.
Therefore, we searched for additional phosphorylation sites in STAT2 by a combi-
nation of mass spectrometry analysis and prediction software (NetPhos 2.0 and
Motif Scan). Serine-287, located in the coiled-coil domain of STAT2, was found
to be phosphorylated in untreated STAT2 null U6A cells reconstituted with wild
type STAT2 but not in cells treated with IFN-a for 20 minutes. To determine the
biological consequence of this putative phosphorylation event, a phosphomimetic
mutant (S287D-STAT2) of STAT2 or a phospho inert mutant (S287A–STAT2) was
expressed in U6A cells. In response to IFN-a, S287D-STAT2 poorly induced ISG
expression and conferred no protection against vesicular stomatitis virus (VSV)
infection, whereas the S287A-STAT2 mutant showed prolonged ISG expression
and lengthened VSV protection. The molecular mechanism behind these phenotyp-
ical changes remains unknown. Yet we observed that STAT2-S287A phosphoryla-
tion on Tyrosine-690 was prolonged whereas S287D-STAT2 activation was
defective in response to type I IFN, resulting in less STAT2 translocating to the
nucleus. Therefore, our study shows that phosphorylation of STAT2 on Serine-
287 negatively impacts STAT2 function in the type I IFN signaling pathway and
suggests that other signaling pathways modulate STAT2 function and the cellular
response to type I IFNs.
doi:10.1016/j.cyto.2010.07.138
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The Janus kinase (JAK) family member tyrosine kinase 2 (Tyk2) is an integral
part of various cytokine and growth hormone signaling pathways. We have
reported previously that macrophages from Tyk2-deficient mice exhibit selective
defects in response to lipopolysaccharide (LPS). We demonstrate now, that LPS
stimulation induces interleukin-17 (IL-17) production via a Tyk2-dependent path-
way in thioglycolate-elicited peritoneal macrophages. IL-17 and IL-17F were upreg-
ulated upon LPS treatment with similar kinetics and both mRNAs were
considerably reduced in the absence of Tyk2. Interestingly, signal transducer and
activator of transcription 3 (STAT3) was not required for LPS-induced IL-17 produc-
tion in macrophages. In the absence of STAT3, IL-17/IL-17F mRNA and IL-17 pro-
tein expression were strongly increased upon LPS treatment and, to a lower
extend, produced constitutively. Thus, in contrast to its essential role in the differ-
entiation/maintenance of IL-17 producing T cells (Th17), STAT3 exerts inhibitory
rather than stimulatory effects on LPS-induced IL-17 production in macrophages.
Of note, we also prove that Tyk2 is indispensable for IL-17 production following
LPS challenge in vivo. We could exclude mature T cells as main source of IL-17
in spleens following intraperitoneal administration of LPS. Currently, we are inves-




STAT1a and STAT1b knockin mice: Initial findings and some surprises
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Signal transducer and activator of transcription 1 (Stat1) participates in Jak-Stat
signalling pathways which (co-) regulate immunity to infection, inflammatory pro-
cesses and carcinogenesis. As a result of alternative splicing Stat1 exists in two iso-
forms, the full length Stat1a and the C-terminal truncated Stat1b isoform. Stat1b
lacks 38 amino acids of the transactivation domain including the serine 727 phos-
phorylation site, which is essential for full transcriptional activation. Previously, it
has been reported that in vitro only Stat1a is transcriptionally active, therefore
Stat1b was considered to act in a dominant negative manner. In order to investigate
the Stat1 isoform functions in vivo we generated mice, which are deficient for either
Stat1a or Stat1b (i.e. Stat1Da/Da and Stat1Db/Db mice, respectively). Protein expres-
sion levels of each isoform are similar to wildtype Stat1a/b expression levels in pri-
mary embryonic fibroblasts (PEFs), bone marrow derived macrophages (BMMUs)
and organs. Upon interferon (IFN) stimulation cells derived from Stat1Db/Dbfnmice
show phosphorylation at tyrosine 701 and serine 727. As expected, in Stat1Da/Da
cells only tyrosine 701 of the Stat1b isoform is phosphorylated. Analysis of respec-
tive cells show that either Stat1 isoform is able to translocate to the nucleus and
to bind to DNA response elements. IFN type I and II induced gene expression of
selected target genes in Stat1Db/Dbfncells is similar to wildtype cells. Unexpectedly,
Stat1Da/Da cells also show gene induction upon IFN type II stimulation. Thus, in con-
trast to what has been shown before in cell lines, these data demonstrate that Stat1b
alone is transcriptionally active. Further analysis will define detailed function of
Stat1a and Stat1b in vivo.
doi:10.1016/j.cyto.2010.07.140
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Signal transducer and activator of transcription 1 (Stat1) is an integral constit-
uent of the Jak-Stat signaling network mediating cellular responses including pro-
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